Search results
Results from the WOW.Com Content Network
TOS can involve only part of the hand (as in the pinky and adjacent half of the ring finger), all of the hand, or the inner aspect of the forearm and upper arm. Pain can also be in the side of the neck, the pectoral area below the clavicle, the armpit/axillary area, and the upper back (i.e., the trapezius and rhomboid area).
Prognosis for patients who have primary tumor sites within the bones often have higher survival rates and respond well to treatment options. [2] While patients who have primary tumor sites within the nasopharynx region with metastases to the breast have very poor outcomes. [ 8 ]
Treatment options for soft-tissue sarcomas include surgery, radiotherapy, chemotherapy, and targeted drug therapy. [3] Surgery is the most common treatment for soft-tissue sarcomas, and usually the only way to achieve a cure. The tumor is removed leaving a safe margin of surrounding healthy tissue to decrease the chances of its recurrence.
Radiation oncology now has simpler, shorter treatment options for breast cancer care, ... Lighter Side. Medicare. News. Science & Tech. Shopping. Sports. Weather. 24/7 Help. For premium support ...
Globally, more than 1.3 million young adults between the ages of 15 and 39 were diagnosed with cancer in 2022, and nearly 378,000 people in this age range died from cancer. [ 2 ] Young adults are more likely than either younger children or older adults to be diagnosed with certain cancers, such as Hodgkin lymphoma , testicular cancer , and some ...
The term "induction regimen" refers to a chemotherapy regimen used for the initial treatment of a disease. A "maintenance regimen" refers to the ongoing use of chemotherapy to reduce the chances of a cancer recurring or to prevent an existing cancer from continuing to grow. [2]
Treatment options for DMMR colorectal cancer can be tricky. On one hand, it tends to be more resistant to chemotherapy, but researchers have now been making inroads with immunotherapy ...
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer